Stroke of Genus: Amgen Inc. v. Sanofi
JD Supra Law
JULY 21, 2023
Supreme Court recently struck down broad patent claims covering a “genus” of antibodies, reaffirming in a 9-0 decision that a patent must “enable” the full scope of its claims (Amgen Inc. Amgen, Inc., Amgen) a biopharmaceutical company, had developed cholesterol-lowering antibody drugs, and obtained two patents.
Let's personalize your content